Evidence map›Paper›PMID 39301788›Full record

ArticleThe Journal of international medical research2024

Evaluation of systemic inflammation markers in patients with Hashimoto's thyroiditis.

Ahmet Bozdag, Pinar Gundogan Bozdag

Abstract read
In one paragraph

Article in The Journal of international medical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ahmet BozdagFirat University School of Medicine, Department of General Surgery, Elazig, Turkey.ORCID 0000-0003-1973-2511
Pinar Gundogan BozdagHealth Sciences University, Elazig Fethi Sekin City Hospital, Department of Radiology, Elazig, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate markers of systemic inflammation and the effect of thyroid dysfunction on these parameters in patients with Hashimoto's thyroiditis (HT).

methodsPatients with HT and volunteer healthy individuals admitted to the general surgery outpatient clinic between January 2020 and June 2023 were enrolled into the study. Patients with HT were divided into euthyroid, hypothyroid, and hyperthyroid subgroups. All participant data were retrospectively extracted from the hospital database.

resultsA total of 268 patients (euthyroid,

conclusionsMarkers of systemic inflammation provide meaningful and reliable information in patients with HT, but do not differentiate between euthyroid, hypothyroid, or hyperthyroid patients.

Indexed as

BiomarkersHashimoto DiseaseInflammationAdultBlood PlateletsCase-Control StudiesFemaleHumansHyperthyroidismHypothyroidismLymphocytesMaleMiddle AgedNeutrophilsRetrospective StudiesBiomarkersHashimoto’s thyroiditishypothyroidisminflammatory indexpan-immune inflammationsystemic inflammation

Identifiers

PMID39301788
PMCPMC11418427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.